Juvena Therapeutics

San Mateo, United States Founded: 2017 • Age: 9 yrs
Protein-based therapies for sarcopenia and muscle regeneration are developed.

About Juvena Therapeutics

Juvena Therapeutics is a Healthcare company based in San Mateo (United States) founded in 2017 by Jeremy O'Connell and Hanadie Yousef. Protein-based therapies for sarcopenia and muscle regeneration are developed. Juvena Therapeutics has raised $75.81 million across 4 funding rounds from investors including HHS, Mubadala and Plum Alley Investments. Its chief executive, as recorded, is Hanadie Yousef. Juvena Therapeutics offers products and services including JUV-161 and Secreted Proteins Platform. Its focus areas include Life Sciences, Orthopedics, Drugs and Muscle Disorders. Its legal entity is Juvena Therapeutics Inc. Its competitors include Altimmune, Carmot and BioAge Labs; 3 of its 3 listed competitors have raised funding.

Company details

Juvena Therapeutics was founded in 2017 in San Mateo, United States, within the biotechnology sector. Protein-based therapeutics are developed by the company to promote tissue generation in the elderly, with a focus on sarcopenia and muscle regeneration. A discovery platform is utilized for screening restored muscle function, which can be extended to other tissue types. A protein cocktail has been created to enhance healing, regeneration, and appearance in aged muscle.

  • Headquarters San Mateo, United States
  • Founders Jeremy O'Connell, Hanadie Yousef
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website juvenatherapeutics.com
  • Social LinkedIn
  • Legal Name Juvena Therapeutics Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $75.81M (USD)

    in 4 rounds

  • Latest Funding Round
    $30.49M (USD), Series A

    Jun 2025

  • Investors
    HHS

    & 13 more

Products & Services of Juvena Therapeutics

Juvena Therapeutics offers a comprehensive portfolio of products and services, including JUV-161 and Secreted Proteins Platform.

JUV-161
Biologic Treatment

Biologic targeting Myotonic Dystrophy Type 1 for muscle degeneration repair

Secreted Proteins Platform
AI Platform

Tool for mapping and engineering proteins to treat metabolic diseases

Funding Insights of Juvena Therapeutics

Juvena Therapeutics has successfully raised a total of $75.81M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $30.49 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $75.81M
  • Total Rounds 4
  • Last Round Series A β€” $30.49M
  • First Round $4.31M

    (Feb 2018)

  • Investors Count 14

All 4 funding rounds of Juvena Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2025$30.49MSeries A––
–
Nov 2022$41MSeries A–Mubadala, Horizons Ventures
Sep 2021$254,262Grant––
Feb 2018$4.31MSeries A––
–
Valuation history

14 investors in total: 13 institutional and 1 angel.

Investors in Juvena Therapeutics

Juvena Therapeutics has secured backing from 14 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, Mubadala and Plum Alley Investments.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Horizons Ventures is focused on investing in deep science and technology.
horizonsventures.comHong Kong, China
Bison Ventures is focused on investing in frontier technology companies.
bison.vcSan Francisco, United States
mantarayventures.com
Venture capital firm focused on Web 3
Seoul, South Korea
Venture capital investing and portfolio management services for accredited investors.
av.vc
Early-stage technology companies are funded by Transform VC.
transform.vcSan Francisco, United States
Early-stage companies are invested in by BoxOne Ventures.
boxone.xyzMontreal, Canada
intersectvc.com
Compound is recognized as a thesis-driven investment firm.
compound.vcNew York, United States
Investments in technology startups are made by Felicis Ventures.
felicis.comMenlo Park, United States
Premium access

Investor details for Juvena Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Juvena Therapeutics

39 people are tracked at Juvena Therapeutics (5 in leadership, 17 in board & advisors, 17 in team).

NameRoleGroup
Jeremy O'Connell
Co-Founder & CSOLeadership
Hanadie Yousef
Co-Founder & CEOLeadership
Fengling Liu
Director of Protein ScienceLeadership
Banmeet Anand
Senior Vice President Drug DevelopmentLeadership
Skanda Goudar
Sr. Director, Alliance Management And Program ManagementLeadership
Stephen Juelsgaard
DirectorBoard & advisors
Patrick Zhang
DirectorBoard & advisors
Irina Conboy
Scientific AdvisorBoard & advisors
Peter Jackson
Scientific AdvisorBoard & advisors
Joe Wu
Scientific AdvisorBoard & advisors
Nicholas E. Johnson
AdvisorBoard & advisors
Jeff Welch
AdvisorBoard & advisors
Ayman Alabdallah
DirectorBoard & advisors
Lawrence Barclay
DirectorBoard & advisors
Ben Hemani
DirectorBoard & advisors
Ameet Mallik
Business AdvisorBoard & advisors
Matthew Fust
Business AdvisorBoard & advisors
Mark Leslie
Business AdvisorBoard & advisors
Mike Nohaile
Business AdvisorBoard & advisors
David Schaffer
Scientific AdvisorBoard & advisors

19 more people are available in the full profile.

Premium access

Complete people profiles for Juvena Therapeutics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Juvena Therapeutics

3 dated milestones of Juvena Therapeutics across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded Juvena Therapeutics is founded.
  2. Funding First funding round of $4.3M.
  3. Funding Latest funding round, Series A, of $30.5M.

Competitors of Juvena Therapeutics

Juvena Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Altimmune, Carmot and BioAge Labs.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
altimmune.com1997Gaithersburg, United States$58M17
Vaccines for infectious diseases and solid tumors are developed.
carmot.us2008Berkeley, United States$385.52M
Disease-modifying therapies for metabolic diseases are developed.
bioagelabs.com2015Vallejo, United States$293.9M43
Bioinformatics platform is provided for biomarkers and drug discovery.
Premium access

Detailed competitors of Juvena Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Juvena Therapeutics

The website of Juvena Therapeutics (juvenatherapeutics.com) receives about 3.4K visits a month.

  • Monthly visits
    3.4K

    ▼ 22.7% vs previous month

Top companies in Orthopedics

3 companies that operate in the same segment as Juvena Therapeutics (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Juvena Therapeutics

Juvena Therapeutics was founded in 2017 and raised its 1st funding round 1 year after it was founded.

Juvena Therapeutics is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.

Hanadie Yousef is the CEO of Juvena Therapeutics, as recorded in our data. They have also founded this company.

Juvena Therapeutics is a funded company, having raised a total of $75.81M across 4 funding rounds to date. The company's 1st funding round was a Series A of $4.31M, raised on Feb 2018.

Juvena Therapeutics was founded in 2017 in San Mateo, United States, within the biotechnology sector. Protein-based therapeutics are developed by the company to promote tissue generation in the elderly, with a focus on sarcopenia and muscle regeneration. A discovery platform is utilized for screening restored muscle function, which can be extended to other tissue types. A protein cocktail has been created to enhance healing, regeneration, and appearance in aged muscle.

Juvena Therapeutics's top competitors include BioAge Labs, Carmot and Altimmune.

Juvena Therapeutics offers JUV-161 and Secreted Proteins Platform.

Juvena Therapeutics has 14 investors. Key investors include HHS, Mubadala, Plum Alley Investments, Horizons Ventures, and Bison Ventures.

Juvena Therapeutics operates through Juvena Therapeutics Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available